These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37151087)

  • 21. Dyspareunia Related to GSM: Association of Total Vaginal Thickness via Transabdominal Ultrasound.
    Balica AC; Cooper AM; McKevitt MK; Schertz K; Wald-Spielman D; Egan S; Bachmann GA
    J Sex Med; 2019 Dec; 16(12):2038-2042. PubMed ID: 31542351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
    Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
    Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal laser therapy for genitourinary syndrome of menopause - systematic review.
    Mension E; Alonso I; Tortajada M; Matas I; Gómez S; Ribera L; Anglès S; Castelo-Branco C
    Maturitas; 2022 Feb; 156():37-59. PubMed ID: 34217581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central and peripheral temperature changes in sheep following ovariectomy.
    MacLeay JM; Lehmer E; Enns RM; Mallinckrodt C; Bryant HU; Turner AS
    Maturitas; 2003 Nov; 46(3):231-8. PubMed ID: 14585527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
    Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
    Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of the objective benefits and safety of Er-YAG laser in the treatment of genitourinary syndrome of menopause.
    Avul Z; Guven CM
    Lasers Med Sci; 2023 Jun; 38(1):131. PubMed ID: 37270721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
    Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É;
    Menopause; 2016 Mar; 23(3):243-56. PubMed ID: 26731686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and benefits of the ewe as a model for vaginal surgery training.
    Kerbage Y; Giraudet G; Rubod C; Garabedian C; Rivaux G; Cosson M
    Int Urogynecol J; 2017 Oct; 28(10):1573-1577. PubMed ID: 28321472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
    Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
    Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update: The Clinical Role of Vaginal Lasers for the Treatment of the Genitourinary Syndrome of Menopause.
    Mounir DM; Hernandez N; Gonzalez RR
    Urology; 2021 May; 151():2-7. PubMed ID: 32966821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genitourinary syndrome of menopause and the use of laser therapy.
    Hutchinson-Colas J; Segal S
    Maturitas; 2015 Dec; 82(4):342-5. PubMed ID: 26323234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Vaginal Microbiota With Signs and Symptoms of the Genitourinary Syndrome of Menopause Across Reproductive Stages.
    Shardell M; Gravitt PE; Burke AE; Ravel J; Brotman RM
    J Gerontol A Biol Sci Med Sci; 2021 Aug; 76(9):1542-1550. PubMed ID: 33903897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of current therapies for genitourinary syndrome of menopause: A Bayesian network analysis of 29 randomized trials and 8311 patients.
    Li B; Duan H; Chang Y; Wang S
    Pharmacol Res; 2021 Feb; 164():105360. PubMed ID: 33307219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
    Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, randomized, open, controlled trial to evaluate the efficacy of Honglilai Vaginal Cream and Premarin Vaginal Cream for Genitourinary Syndrome of Menopause in different subgroups of Chinese postmenopausal women.
    Yang M; Lin S; Zheng S; Sun A; Bian M; Li S; Liu J; Hu L; Hui N; Zhong J; Hou H; Yue T; Gao X; Bai W
    Gynecol Endocrinol; 2022 Oct; 38(10):861-867. PubMed ID: 36067791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.
    Faubion SS; Larkin LC; Stuenkel CA; Bachmann GA; Chism LA; Kagan R; Kaunitz AM; Krychman ML; Parish SJ; Partridge AH; Pinkerton JV; Rowen TS; Shapiro M; Simon JA; Goldfarb SB; Kingsberg SA
    Menopause; 2018 Jun; 25(6):596-608. PubMed ID: 29762200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of pathophysiological changes in the vaginal milieu on the signs and symptoms of genitourinary syndrome of menopause (GSM).
    Qi W; Li H; Wang C; Li H; Fan A; Han C; Xue F
    Menopause; 2020 Aug; 28(1):102-108. PubMed ID: 32810079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation on prevalence and risk factors associated with genitourinary syndrome of menopause in middle-aged and older women in Beijing community: a cross sectional study.
    Zhu Y; Wei J; Yang X; Zhu W; Zhang W
    BMC Womens Health; 2022 Dec; 22(1):558. PubMed ID: 36585649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
    Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study.
    Palma F; Volpe A; Villa P; Cagnacci A;
    Maturitas; 2016 Jan; 83():40-4. PubMed ID: 26421474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.